查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經膠質瘤治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按疾病、治療類型、等級、最終用戶和地理位置
市場調查報告書
商品編碼
1362435

神經膠質瘤治療市場規模和預測、全球和區域佔有率、趨勢和成長機會分析報告範圍：按疾病、治療類型、等級、最終用戶和地理位置

Glioma Treatment Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 182 Pages | 訂單完成後即時交付

價格

全球神經膠質瘤治療市場預計將從2022年的 41.396 億美元增至2030年的 82.925 億美元。預計2022年至2030年該市場將以 9.1%的年複合成長率成長。

該市場的成長是由於高級別神經膠質瘤的盛行率不斷增加，包括侵襲性腦腫瘤，如膠質母細胞瘤、間變性星狀細胞瘤和少突膠質細胞瘤。然而，高昂的處理成本在一定程度上阻礙了市場的成長。

膠質瘤治療市場的市場機會

巴西、印度、中國、俄羅斯和南非是世界上成長最快的經濟體之一。這些國家和其他發展中經濟體的醫療保健產業預計在未來幾年將迅速擴張。預期成長是由於客戶需求的變化、醫療保健服務意識的增強以及人口老化的持續成長。隨著醫療保健產業的蓬勃發展，全球腦癌治療市場可能在未來幾年顯著成長。

阻礙神經膠質瘤治療市場的因素

治療腦腫瘤可能很昂貴，而高昂的治療費用成為患者壓力和焦慮的原因之一。除了治療費用外，人們還需要承擔與患者護理相關的額外計劃外費用。高昂的醫療費用迫使人們停止治療計劃，這可能會使他們的健康面臨風險，並導致未來進一步的費用。根據國家醫學圖書館的資料，新診斷的、經替莫唑胺治療(TMZ)GBM 的直接醫療費用對於商業保險患者來說是巨大的，估計總累積費用約為 268,031 美元。惡性腦瘤患者所承擔的醫療費用比具有相同人口統計的非癌症對照組高出20 倍。

神經膠質瘤治療市場：細分概述

神經膠質瘤治療市場依類型分為星狀細胞瘤、少突星狀細胞瘤和少突膠質細胞瘤。星狀細胞瘤細分市場在2022年佔據最大的市場佔有率。此外，預計該細分市場從2022年到2030年的年複合成長率最高。隨著該疾病患病率的不斷增加，提高公眾對此疾病及其治療認知的活動激增，是推動神經膠質瘤治療市場成長的主要因素之一。此外，間變性星狀細胞瘤市場的公司可能會從不斷成長的研發努力和新的、未開發的細分市場中獲得成長機會。根據治療，神經膠質瘤治療市場分為手術、化療、放射治療等。2022年，手術領域佔最大市場佔有率。此外，預計從2022年到2030年，同一細分市場的需求將以最快的年複合成長率成長，因為手術是最優選的技術，因為它可以完全切除腫瘤。根據級別，神經膠質瘤治療市場分為低級別和高級別。2022年，高檔細分市場佔據最大市場佔有率。此外，預計從2022年到2030年，同一細分市場的需求將以最快的年複合成長率成長。多項研究進行中，以更佳了解高級別腫瘤，以開發更有效的治療或療法。神經膠質瘤治療市場根據最終用戶分為醫院和診所以及門診護理中心。2022年，醫院和診所領域佔據最大的市場。此外，預計同一細分市場的需求將從2022年到2030年以最快的年複合成長率成長。此外，發展中國家醫院數量的增加、先進診斷平台的採用以及醫院的可及性不斷提高將為成長提供利潤豐厚的機會預測期內醫院部門的神經膠質瘤治療市場。

神經膠質瘤治療市場：地理概況

北美在全球神經膠質瘤治療市場中佔有最大佔有率，而亞太地區則是全球神經膠質瘤治療市場成長最快的地區。北美市場預計在預測期內將成長，這主要是由於腦腫瘤盛行率不斷上升、神經膠質瘤治療技術進步以及吸菸者數量不斷增加所推動的。亞太地區在全球神經膠質瘤治療測試市場中年複合成長率最高。未來幾年，中國、印度和日本等國家的市場預計將大幅成長。由於腦癌治療需求的增加和腦腫瘤盛行率的上升，亞太市場預計將成長。因此，該地區的神經膠質瘤治療市場參與者在預測期內具有巨大的成長潛力。

在準備神經膠質瘤治療市場報告時提到的一些主要和次要來源包括世界銀行資料、國家醫療服務體系(NHS)、FDA(食品和藥物管理局)、EMA(歐洲藥品管理局)和EPA (環保署)。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 神經膠質瘤治療市場格局

  • 概述
  • PEST分析
    • 全球PEST分析

第5章 神經膠質瘤治療市場 - 主要產業動態

  • 市場促進因素
    • 地區和州政府為患者提供治療的舉措
    • 高惡性度膠質瘤盛行率增加
  • 主要市場限制
    • 診斷費用高
  • 主要市場機會
    • 新興經濟體醫療保健產業的進步
  • 未來的趨勢
    • 神經膠質瘤治療藥物核准激增
  • 影響分析：

第6章 神經膠質瘤治療市場 - 全球市場分析

  • 神經膠質瘤治療市場收入，2022 -2030

第7章 全球膠質瘤治療市場 -2030年收入和預測 - 按疾病分類

  • 概述
  • 2022年和2030年按疾病分類的神經膠質瘤治療市場收入佔有率(%)
  • 星狀細胞瘤
  • 寡星狀細胞瘤
  • 寡樹突膠質瘤

第8章 全球膠質瘤治療市場 -2030年收入和預測 - 按治療類型

  • 概述
  • 2022年和2030年按治療類型分類的神經膠質瘤治療市場收入佔有率(%)
  • 手術
  • 化療
  • 放射治療
  • 其他

第9章 全球膠質瘤治療市場 - 收入和2030年預測 - 按級別

  • 概述
  • 2022年和2030年神經膠質瘤治療市場收入佔有率(按年級分類)
  • 低等級
  • 高等級

第10章 全球神經膠質瘤治療市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年和2030年最終用戶神經膠質瘤治療市場收入佔有率(%)
  • 醫院及診所
  • 門診手術中心

第11章 神經膠質瘤治療市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第12章 Covid-19 前後的影響

  • Covid-19 前後的影響

第13章 神經膠質瘤治療市場產業格局

  • 概述
  • 市場上公司採取的成長策略，(%)
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第14章 公司簡介

  • F. Hoffmann-La Roche Ltd
  • Arbor Pharmaceuticals LLC
  • Merck & Co Inc
  • Sun Pharmaceutical Industries Ltd
  • Amgen Inc
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc
  • Amneal Pharmaceuticals Inc
  • Karyopharm Therapeutics Inc
  • Biocon Ltd

第15章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00029993

The global glioma treatment market is expected to reach US$ 8,292.5 million in 2030 from US$ 4,139.6 million in 2022. The market is projected to grow with a CAGR of 9.1% from 2022 to 2030.

The market's growth is the increasing prevalence of high-grade gliomas, including aggressive brain tumors such as glioblastomas, anaplastic astrocytomas, and oligodendrogliomas. However, high treatment costs hamper the market's growth to a certain extent.

Market Opportunities of Glioma Treatment Market

Brazil, India, China, Russia, and South Africa are among the fastest-growing economies in the world. The healthcare sectors in these countries and other developing economies are projected to expand rapidly in the coming years. The expected growth is due to changes in customer demand, increased awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer treatment market is likely to grow significantly in the coming years with the proliferation of the healthcare sector.

Factors Hampering Glioma Treatment Market

Treating brain tumors can be expensive, and the high cost of treatments becomes a cause of stress and anxiety for patients. In addition to the treatment cost, people need to bear additional unplanned costs related to patient care. High medical costs compel people to discontinue their treatment plans, which may put their health at risk and lead to further costs in the future. According to the National Library of Medicine, the direct medical costs of newly diagnosed, Temozolomide-treated (TMZ) GBM are substantial in commercially insured patients, with estimated total cumulative costs of ~US$ 268,031. The healthcare costs incurred by patients with malignant brain tumors are 20 times higher than those borne by non-cancer control groups with the same demographics.

Glioma Treatment Market: Segmental Overview

The glioma treatment market is segmented based on type into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest market share in 2022. Furthermore, the segment is expected to register the highest CAGR from 2022 to 2030. An upsurge in activities to raise public awareness of this condition and its treatment, coupled with the increasing prevalence of this disease, are among the major factors fueling the glioma treatment market growth. In addition, companies in the market for the anaplastic astrocytoma segment may derive growth opportunities from growing R&D efforts and new, untapped market segments. Based on treatment, the glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. In 2022, the surgery segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030, owing to the surgery being the most preferred technique as it removes the tumor completely. Based on grade, the glioma treatment market is segmented into Low Grade and High Grade. In 2022, the high-grade segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030. Multiple research studies are underway to understand better high-grade tumors to develop more effective treatments or therapies. The glioma treatment market is segmented based on end-users into hospitals & clinics, and ambulatory care centres. In 2022, the hospital & clinics segment held the largest market share. Furthermore, the same segment is expected to anticipate growth in demand at the fastest CAGR from 2022 to 2030. Further, the increasing number of hospitals, adoption of advanced diagnostic platforms, and growing accessibility of hospitals in developing nations would offer lucrative opportunities for the growth of the glioma treatment market for the hospital segment during the forecast period.

Glioma Treatment Market: Geographical Overview

North America holds the largest share of the global glioma treatment market, whereas the Asia Pacific is the fastest-growing region in the global glioma treatment market. The market in North America is expected to grow during the forecast period, primarily driven by the increasing prevalence of brain tumors, technological advancements in glioma treatment, and the rising number of smokers. Asia Pacific registered the highest CAGR in the global glioma treatment testing market. The market in the region is expected to grow significantly in countries including China, India, and Japan in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for brain cancer treatments and the rising prevalence of brain tumors. Therefore, the region holds huge potential for the glioma treatment market players to grow during the forecast period.

A few of the primary and secondary sources referred to while preparing the report on the glioma treatment market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and EPA (Environmental Protection Agency).

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the glioma treatment.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global glioma treatment, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global glioma treatment trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Glioma Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Glioma Treatment Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Initiatives by Regional and State Governments to Provide Patients Access to Treatment
    • 5.1.2 Increase in Prevalence of High-Grade Glioma
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Diagnosis
  • 5.3 Key Market Opportunities
    • 5.3.1 Advancements in Healthcare Sector in Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Surge in Drug Approvals for Glioma Treatment
  • 5.5 Impact Analysis:

6. Glioma Treatment Market - Global Market Analysis

  • 6.1 Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

  • 7.1 Overview
  • 7.2 Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
  • 7.3 Astrocytoma
    • 7.3.1 Overview
    • 7.3.2 Astrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Oligoastrocytoma
    • 7.4.1 Overview
    • 7.4.2 Oligoastrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Oligodendroglioma
    • 7.5.1 Overview
    • 7.5.2 Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

  • 8.1 Overview
  • 8.2 Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • 8.3 Surgery
    • 8.3.1 Overview
    • 8.3.2 Surgery: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Chemotherapy
    • 8.4.1 Overview
    • 8.4.2 Chemotherapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Radiation Therapy
    • 8.5.1 Overview
    • 8.5.2 Radiation Therapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

  • 9.1 Overview
  • 9.2 Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
  • 9.3 Low Grade
    • 9.3.1 Overview
    • 9.3.2 Low Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.1 Grade I: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.3.2.2 Grade II: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 High Grade
    • 9.4.1 Overview
    • 9.4.2 High Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.1 Grade III: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
      • 9.4.2.2 Grade IV: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospital & Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospital & Clinics: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Overview
    • 10.4.2 Ambulatory Surgical Centers: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. Glioma Treatment Market - Geographical Analysis

  • 11.1 North America Glioma Treatment Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America Glioma Treatment Market, by Disease
    • 11.1.4 North America Glioma Treatment Market, by Treatment Type
    • 11.1.5 North America Glioma Treatment Market, by Grade
      • 11.1.5.1 North America Glioma Treatment Market, by Low Grade
      • 11.1.5.2 North America Glioma Treatment Market, by High Grade
    • 11.1.6 North America Glioma Treatment Market, by End User
    • 11.1.7 North America Glioma Treatment Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.2 US Glioma Treatment Market, by Disease
        • 11.1.7.1.3 US Glioma Treatment Market, by Treatment Type
        • 11.1.7.1.4 US Glioma Treatment Market, by Grade
        • 11.1.7.1.4.1 US Glioma Treatment Market, by Low Grade
        • 11.1.7.1.4.2 US Glioma Treatment Market, by High Grade
        • 11.1.7.1.5 US Glioma Treatment Market, by End User
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.2 Canada Glioma Treatment Market, by Disease
        • 11.1.7.2.3 Canada Glioma Treatment Market, by Treatment Type
        • 11.1.7.2.4 Canada Glioma Treatment Market, by Grade
        • 11.1.7.2.4.1 Canada Glioma Treatment Market, by Low Grade
        • 11.1.7.2.4.2 Canada Glioma Treatment Market, by High Grade
        • 11.1.7.2.5 Canada Glioma Treatment Market, by End User
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.2 Mexico Glioma Treatment Market, by Disease
        • 11.1.7.3.3 Mexico Glioma Treatment Market, by Treatment Type
        • 11.1.7.3.4 Mexico Glioma Treatment Market, by Grade
        • 11.1.7.3.4.1 Mexico Glioma Treatment Market, by Low Grade
        • 11.1.7.3.4.2 Mexico Glioma Treatment Market, by High Grade
        • 11.1.7.3.5 Mexico Glioma Treatment Market, by End User
  • 11.2 Europe Glioma Treatment Market, Revenue and Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Glioma Treatment Market, by Disease
    • 11.2.4 Europe Glioma Treatment Market, by Treatment Type
    • 11.2.5 Europe Glioma Treatment Market, by Grade
      • 11.2.5.1 Europe Glioma Treatment Market, by Low Grade
      • 11.2.5.2 Europe Glioma Treatment Market, by High Grade
    • 11.2.6 Europe Glioma Treatment Market, by End User
    • 11.2.7 Europe Glioma Treatment Market, by Country
      • 11.2.7.1 UK
        • 11.2.7.1.1 UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.1.2 UK Glioma Treatment Market, by Disease
        • 11.2.7.1.3 UK Glioma Treatment Market, by Treatment Type
        • 11.2.7.1.4 UK Glioma Treatment Market, by Grade
        • 11.2.7.1.4.1 UK Glioma Treatment Market, by Low Grade
        • 11.2.7.1.4.2 UK Glioma Treatment Market, by High Grade
        • 11.2.7.1.5 UK Glioma Treatment Market, by End User
      • 11.2.7.2 Germany
        • 11.2.7.2.1 Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.2 Germany Glioma Treatment Market, by Disease
        • 11.2.7.2.3 Germany Glioma Treatment Market, by Treatment Type
        • 11.2.7.2.4 Germany Glioma Treatment Market, by Grade
        • 11.2.7.2.4.1 Germany Glioma Treatment Market, by Low Grade
        • 11.2.7.2.4.2 Germany Glioma Treatment Market, by High Grade
        • 11.2.7.2.5 Germany Glioma Treatment Market, by End User
      • 11.2.7.3 France
        • 11.2.7.3.1 France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.2 France Glioma Treatment Market, by Disease
        • 11.2.7.3.3 France Glioma Treatment Market, by Treatment Type
        • 11.2.7.3.4 France Glioma Treatment Market, by Grade
        • 11.2.7.3.4.1 France Glioma Treatment Market, by Low Grade
        • 11.2.7.3.4.2 France Glioma Treatment Market, by High Grade
        • 11.2.7.3.5 France Glioma Treatment Market, by End User
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.4.2 Italy Glioma Treatment Market, by Disease
        • 11.2.7.4.3 Italy Glioma Treatment Market, by Treatment Type
        • 11.2.7.4.4 Italy Glioma Treatment Market, by Grade
        • 11.2.7.4.4.1 Italy Glioma Treatment Market, by Low Grade
        • 11.2.7.4.4.2 Italy Glioma Treatment Market, by High Grade
        • 11.2.7.4.5 Italy Glioma Treatment Market, by End User
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.2 Spain Glioma Treatment Market, by Disease
        • 11.2.7.5.3 Spain Glioma Treatment Market, by Treatment Type
        • 11.2.7.5.4 Spain Glioma Treatment Market, by Grade
        • 11.2.7.5.4.1 Spain Glioma Treatment Market, by Low Grade
        • 11.2.7.5.4.2 Spain Glioma Treatment Market, by High Grade
        • 11.2.7.5.5 Spain Glioma Treatment Market, by End User
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.2 Rest of Europe Glioma Treatment Market, by Disease
        • 11.2.7.6.3 Rest of Europe Glioma Treatment Market, by Treatment Type
        • 11.2.7.6.4 Rest of Europe Glioma Treatment Market, by Grade
        • 11.2.7.6.4.1 Rest of Europe Glioma Treatment Market, by Low Grade
        • 11.2.7.6.4.2 Rest of Europe Glioma Treatment Market, by High Grade
        • 11.2.7.6.5 Rest of Europe Glioma Treatment Market, by End User
  • 11.3 Asia Pacific Glioma Treatment Market, Revenue and Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific Glioma Treatment Market, by Disease
    • 11.3.4 Asia Pacific Glioma Treatment Market, by Treatment Type
    • 11.3.5 Asia Pacific Glioma Treatment Market, by Grade
      • 11.3.5.1 Asia Pacific Glioma Treatment Market, by Low Grade
      • 11.3.5.2 Asia Pacific Glioma Treatment Market, by High Grade
    • 11.3.6 Asia Pacific Glioma Treatment Market, by End User
    • 11.3.7 Asia Pacific Glioma Treatment Market, by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.1.2 China Glioma Treatment Market, by Disease
        • 11.3.7.1.3 China Glioma Treatment Market, by Treatment Type
        • 11.3.7.1.4 China Glioma Treatment Market, by Grade
        • 11.3.7.1.4.1 China Glioma Treatment Market, by Low Grade
        • 11.3.7.1.4.2 China Glioma Treatment Market, by High Grade
        • 11.3.7.1.5 China Glioma Treatment Market, by End User
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.2 Japan Glioma Treatment Market, by Disease
        • 11.3.7.2.3 Japan Glioma Treatment Market, by Treatment Type
        • 11.3.7.2.4 Japan Glioma Treatment Market, by Grade
        • 11.3.7.2.4.1 Japan Glioma Treatment Market, by Low Grade
        • 11.3.7.2.4.2 Japan Glioma Treatment Market, by High Grade
        • 11.3.7.2.5 Japan Glioma Treatment Market, by End User
      • 11.3.7.3 India
        • 11.3.7.3.1 India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.2 India Glioma Treatment Market, by Disease
        • 11.3.7.3.3 India Glioma Treatment Market, by Treatment Type
        • 11.3.7.3.4 India Glioma Treatment Market, by Grade
        • 11.3.7.3.4.1 India Glioma Treatment Market, by Low Grade
        • 11.3.7.3.4.2 India Glioma Treatment Market, by High Grade
        • 11.3.7.3.5 India Glioma Treatment Market, by End User
      • 11.3.7.4 South Korea
        • 11.3.7.4.1 South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.4.2 South Korea Glioma Treatment Market, by Disease
        • 11.3.7.4.3 South Korea Glioma Treatment Market, by Treatment Type
        • 11.3.7.4.4 South Korea Glioma Treatment Market, by Grade
        • 11.3.7.4.4.1 South Korea Glioma Treatment Market, by Low Grade
        • 11.3.7.4.4.2 South Korea Glioma Treatment Market, by High Grade
        • 11.3.7.4.5 South Korea Glioma Treatment Market, by End User
      • 11.3.7.5 Australia
        • 11.3.7.5.1 Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.2 Australia Glioma Treatment Market, by Disease
        • 11.3.7.5.3 Australia Glioma Treatment Market, by Treatment Type
        • 11.3.7.5.4 Australia Glioma Treatment Market, by Grade
        • 11.3.7.5.4.1 Australia Glioma Treatment Market, by Low Grade
        • 11.3.7.5.4.2 Australia Glioma Treatment Market, by High Grade
        • 11.3.7.5.5 Australia Glioma Treatment Market, by End User
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.2 Rest of Asia Pacific Glioma Treatment Market, by Disease
        • 11.3.7.6.3 Rest of Asia Pacific Glioma Treatment Market, by Treatment Type
        • 11.3.7.6.4 Rest of Asia Pacific Glioma Treatment Market, by Grade
        • 11.3.7.6.4.1 Rest of Asia Pacific Glioma Treatment Market, by Low Grade
        • 11.3.7.6.4.2 Rest of Asia Pacific Glioma Treatment Market, by High Grade
        • 11.3.7.6.5 Rest of Asia Pacific Glioma Treatment Market, by End User
  • 11.4 Middle East & Africa Glioma Treatment Market, Revenue and Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Glioma Treatment Market, by Disease
    • 11.4.4 Middle East & Africa Glioma Treatment Market, by Treatment Type
    • 11.4.5 Middle East & Africa Glioma Treatment Market, by Grade
      • 11.4.5.1 Middle East & Africa Glioma Treatment Market, by Low Grade
      • 11.4.5.2 Middle East & Africa Glioma Treatment Market, by High Grade
    • 11.4.6 Middle East & Africa Glioma Treatment Market, by End User
    • 11.4.7 Middle East & Africa Glioma Treatment Market, by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.1.2 Saudi Arabia Glioma Treatment Market, by Disease
        • 11.4.7.1.3 Saudi Arabia Glioma Treatment Market, by Treatment Type
        • 11.4.7.1.4 Saudi Arabia Glioma Treatment Market, by Grade
        • 11.4.7.1.4.1 Saudi Arabia Glioma Treatment Market, by Low Grade
        • 11.4.7.1.4.2 Saudi Arabia Glioma Treatment Market, by High Grade
        • 11.4.7.1.5 Saudi Arabia Glioma Treatment Market, by End User
      • 11.4.7.2 South Africa
        • 11.4.7.2.1 South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.2 South Africa Glioma Treatment Market, by Disease
        • 11.4.7.2.3 South Africa Glioma Treatment Market, by Treatment Type
        • 11.4.7.2.4 South Africa Glioma Treatment Market, by Grade
        • 11.4.7.2.4.1 South Africa Glioma Treatment Market, by Low Grade
        • 11.4.7.2.4.2 South Africa Glioma Treatment Market, by High Grade
        • 11.4.7.2.5 South Africa Glioma Treatment Market, by End User
      • 11.4.7.3 UAE
        • 11.4.7.3.1 UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.2 UAE Glioma Treatment Market, by Disease
        • 11.4.7.3.3 UAE Glioma Treatment Market, by Treatment Type
        • 11.4.7.3.4 UAE Glioma Treatment Market, by Grade
        • 11.4.7.3.4.1 UAE Glioma Treatment Market, by Low Grade
        • 11.4.7.3.4.2 UAE Glioma Treatment Market, by High Grade
        • 11.4.7.3.5 UAE Glioma Treatment Market, by End User
      • 11.4.7.4 Rest of Middle East & Africa
        • 11.4.7.4.1 Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.4.2 Rest of Middle East & Africa Glioma Treatment Market, by Disease
        • 11.4.7.4.3 Rest of Middle East & Africa Glioma Treatment Market, by Treatment Type
        • 11.4.7.4.4 Rest of Middle East & Africa Glioma Treatment Market, by Grade
        • 11.4.7.4.4.1 Rest of Middle East & Africa Glioma Treatment Market, by Low Grade
        • 11.4.7.4.4.2 Rest of Middle East & Africa Glioma Treatment Market, by High Grade
        • 11.4.7.4.5 Rest of Middle East & Africa Glioma Treatment Market, by End User
  • 11.5 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Glioma Treatment Market, by Disease
    • 11.5.4 South & Central America Glioma Treatment Market, by Treatment Type
    • 11.5.5 South & Central America Glioma Treatment Market, by Grade
      • 11.5.5.1 South & Central America Glioma Treatment Market, by Low Grade
      • 11.5.5.2 South & Central America Glioma Treatment Market, by High Grade
    • 11.5.6 South & Central America Glioma Treatment Market, by End User
      • 11.5.6.1 South & Central America Glioma Treatment Market, by Country
      • 11.5.6.2 Brazil
        • 11.5.6.2.1 Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.2.2 Brazil Glioma Treatment Market, by Disease
        • 11.5.6.2.3 Brazil Glioma Treatment Market, by Treatment Type
        • 11.5.6.2.4 Brazil Glioma Treatment Market, by Grade
        • 11.5.6.2.4.1 Brazil Glioma Treatment Market, by Low Grade
        • 11.5.6.2.4.2 Brazil Glioma Treatment Market, by High Grade
        • 11.5.6.2.5 Brazil Glioma Treatment Market, by End User
      • 11.5.6.3 Argentina
        • 11.5.6.3.1 Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.3.2 Argentina Glioma Treatment Market, by Disease
        • 11.5.6.3.3 Argentina Glioma Treatment Market, by Treatment Type
        • 11.5.6.3.4 Argentina Glioma Treatment Market, by Grade
        • 11.5.6.3.4.1 Argentina Glioma Treatment Market, by Low Grade
        • 11.5.6.3.4.2 Argentina Glioma Treatment Market, by High Grade
        • 11.5.6.3.5 Argentina Glioma Treatment Market, by End User
      • 11.5.6.4 Rest of South & Central America
        • 11.5.6.4.1 Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.6.4.2 Rest of South & Central America Glioma Treatment Market, by Disease
        • 11.5.6.4.3 Rest of South & Central America Glioma Treatment Market, by Treatment Type
        • 11.5.6.4.4 Rest of South & Central America Glioma Treatment Market, by Grade
        • 11.5.6.4.4.1 Rest of South & Central America Glioma Treatment Market, by Low Grade
        • 11.5.6.4.4.2 Rest of South & Central America Glioma Treatment Market, by High Grade
        • 11.5.6.4.5 Rest of South & Central America Glioma Treatment Market, by End User

12. Pre & Post Covid-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. Glioma Treatment Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market, (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 F. Hoffmann-La Roche Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Arbor Pharmaceuticals LLC
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Merck & Co Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sun Pharmaceutical Industries Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Amgen Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Teva Pharmaceutical Industries Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Pfizer Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Amneal Pharmaceuticals Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Karyopharm Therapeutics Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Biocon Ltd
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Glioma Treatment Market Segmentation
  • Table 2. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 3. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 4. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 5. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 6. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 7. North America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 8. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 9. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 10. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 11. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 12. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 13. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 15. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 16. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 17. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 18. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 19. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 20. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 21. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 22. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 23. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 24. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 25. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 27. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 28. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 29. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 30. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 31. Europe Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 33. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 34. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 36. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 37. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 38. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 39. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 40. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 41. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 42. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 43. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 44. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 45. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 46. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 47. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 48. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 49. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 50. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 51. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 52. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 53. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 54. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 55. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 56. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 57. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 58. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 59. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 60. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 61. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 62. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 63. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 64. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 65. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 66. Rest of Europe Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 67. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 68. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 69. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 70. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 71. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 72. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 73. Asia Pacific Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 74. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 75. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 76. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 77. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 78. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 79. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 80. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 81. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 82. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 83. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 84. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 85. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 86. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 87. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 88. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 89. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 90. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 91. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 92. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 93. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 94. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 95. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 96. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
  • Table 97. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 98. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 99. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 100. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 101. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 102. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 103. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 104. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 105. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 106. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 107. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 108. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 109. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 110. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 111. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 112. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 113. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 114. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 115. Middle East & Africa Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 116. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 117. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 118. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 119. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 120. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 121. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 122. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 123. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 124. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 125. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 126. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 127. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 128. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 129. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 130. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 131. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 132. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 133. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 134. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 135. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 136. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 137. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 138. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 139. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 140. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 141. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 142. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 143. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 144. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 145. South & Central America Glioma Treatment Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 146. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 147. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 148. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 149. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 150. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 151. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 152. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 153. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 154. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 155. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
  • Table 156. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
  • Table 157. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 158. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
  • Table 159. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
  • Table 160. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
  • Table 161. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
  • Table 162. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
  • Table 163. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 164. Organic Developments Done By Companies
  • Table 165. Inorganic Developments Done By Companies
  • Table 166. Glossary of Terms, glioma treatment market

List Of Figures

  • Figure 1. Glioma Treatment Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Glioma Treatment Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Glioma Treatment Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 7. Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
  • Figure 8. Astrocytoma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Oligodendroglioma: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
  • Figure 12. Surgery: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Chemotherapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Radiation Therapy: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
  • Figure 17. Low Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Grade I: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Grade II: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. High Grade: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Grade III: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Grade IV: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 24. Hospital & Clinics: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Ambulatory Surgical Centers: Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Glioma Treatment Market, 2022 ($Mn)
  • Figure 27. North America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. North America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 29. US Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Canada Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Mexico Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Europe Glioma Treatment Market, By Geography, 2022 ($Mn)
  • Figure 33. Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Europe Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 35. UK Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Germany Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. France Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Italy Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Spain Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Rest of Europe Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 41. Glioma Treatment Market, By Geography, 2022 ($Mn)
  • Figure 42. Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Asia Pacific Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 44. China Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. Japan Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. India Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. South Korea Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Australia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Rest of Asia Pacific Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 50. Glioma Treatment Market, By Geography, 2022 ($Mn)
  • Figure 51. Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 52. Middle East & Africa Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 53. Saudi Arabia Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. South Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. UAE Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Rest of Middle East & Africa Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 57. Glioma Treatment Market, By Geography, 2022 ($Mn)
  • Figure 58. South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 59. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
  • Figure 60. Brazil Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Argentina Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. Rest of South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 63. Pre & Post Covid-19 Impact
  • Figure 64. Growth Strategies Done by the Companies in the Market, (%)